Literature DB >> 8978444

Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment.

M Filippi1, M Rovaris, G Comi.   

Abstract

In this review the main contributions of magnetic resonance (MR) techniques in the monitoring of multiple sclerosis (MS) course, both natural or modified by treatments, are presented. MR measures well correlate with short-term disease evolution and therefore their use is appropriate as primary end-points in preliminary clinical trials evaluating the effects of new treatments. In contrast, the correlation between MR measures and long-term clinical evolution in clinically definite MS is less clear, thus indicating that such measures can be used at present only as a secondary end-point in large scale definitive trials. The results coming from the clinical application of newer MR techniques with higher pathological specificity are also presented and their possible future roles in monitoring treatment aimed at preventing development of disability in MS are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8978444     DOI: 10.1007/bf01997712

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  69 in total

1.  Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration.

Authors:  A J Thompson; D Miller; B Youl; D MacManus; S Moore; D Kingsley; B Kendall; A Feinstein; W I McDonald
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

2.  Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history.

Authors:  J O Harris; J A Frank; N Patronas; D E McFarlin; H F McFarland
Journal:  Ann Neurol       Date:  1991-05       Impact factor: 10.422

3.  Analysis of brain and cerebrospinal fluid volumes with MR imaging. Part I. Methods, reliability, and validation.

Authors:  M I Kohn; N K Tanna; G T Herman; S M Resnick; P D Mozley; R E Gur; A Alavi; R A Zimmerman; R C Gur
Journal:  Radiology       Date:  1991-01       Impact factor: 11.105

4.  Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery.

Authors:  M Filippi; T Yousry; C Baratti; M A Horsfield; S Mammi; C Becker; R Voltz; S Spuler; A Campi; M F Reiser; G Comi
Journal:  Brain       Date:  1996-08       Impact factor: 13.501

5.  Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques.

Authors:  M Filippi; M A Horsfield; S Bressi; V Martinelli; C Baratti; P Reganati; A Campi; D H Miller; G Comi
Journal:  Brain       Date:  1995-12       Impact factor: 13.501

6.  A comparison of the pathology of primary and secondary progressive multiple sclerosis.

Authors:  T Revesz; D Kidd; A J Thompson; R O Barnard; W I McDonald
Journal:  Brain       Date:  1994-08       Impact factor: 13.501

7.  Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis.

Authors:  A Gass; G J Barker; D Kidd; J W Thorpe; D MacManus; A Brennan; P S Tofts; A J Thompson; W I McDonald; D H Miller
Journal:  Ann Neurol       Date:  1994-07       Impact factor: 10.422

8.  Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study.

Authors:  M Filippi; G J Barker; M A Horsfield; P R Sacares; D G MacManus; A J Thompson; P S Tofts; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

9.  Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis.

Authors:  D H Miller; F Barkhof; J J Nauta
Journal:  Brain       Date:  1993-10       Impact factor: 13.501

10.  A spinal cord MRI study of benign and secondary progressive multiple sclerosis.

Authors:  M Filippi; A Campi; B Colombo; C Pereira; V Martinelli; C Baratti; G Comi
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

View more
  1 in total

Review 1.  Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

Authors:  Richard K Burt; Shimon Slavin; William H Burns; Alberto M Marmont
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.319

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.